Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Pediatrix Medical Group (MD) is a Top-Ranked Growth Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Pediatrix Ties Up to Provide Better Maternal Care in Tennessee
MD expands maternal care in Tennessee through a new partnership, boosts high-risk pregnancy services and aims for immediate earnings accretion.
Here's Why Investors Continue to Hold Pediatrix Medical Stock
Favorable payer mix, higher neonatology acuity and prudent acquisitions will support MD's growth, while shares look undervalued versus industry peers.
Why Pediatrix Medical Group (MD) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Pediatrix Medical Q4 Earnings Miss Estimates Despite Declining Costs
MD's Q4 EPS miss estimates as revenues dip, but same-unit gains and a stronger 2026 EBITDA outlook signal mixed momentum.
Pediatrix Medical Group (MD) Q4 Earnings Lag Estimates
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.5 per share, missing the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $0.51 per share a year ago.
Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio
MD is positioned for growth on stronger collections, payer mix and acquisitions, as shares jump 55.2% in six months, beating the industry's 6.7% gain.
Why Is Pediatrix Medical Group (MD) Up 11.1% Since Last Earnings Report?
Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?
Pediatrix Medical Group, Inc. (MD) Hit a 52 Week High, Can the Run Continue?
Pediatrix Medical Group (MD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Pediatrix Medical Q3 Earnings Beat Estimates on Declining Expenses
MD's Q3 profit tops on lower expenses and improved patient acuity, driving earnings past estimates despite softer revenues.
